'idelalisib'这个词语来源于英语,是一种药物名称,常被翻译为伊替达利珠。它是一种治疗淋巴瘤和白血病的药物,属于一种磷脂酰肌醇3-激酶(PI3K)抑制剂。
以下是9个含有'idelalisib'的例句:
1. Idelalisib is a novel, highly selective oral inhibitor of PI3Kδ.(伊替达利珠是一种新颖、高度选择性的口服PI3Kδ抑制剂。)
2. Idelalisib shows promising efficacy in the treatment of chronic lymphocytic leukemia.(伊替达利珠在慢性淋巴细胞白血病的治疗中显示出良好的疗效。)
3. Idelalisib is typically administered as a tablet twice daily.(伊替达利珠通常每日两次口服片剂。)
4. Although idelalisib is generally well-tolerated, it can cause serious adverse events.(尽管伊替达利珠一般耐受性良好,但也可能引发严重不良反应。)
5. Idelalisib selectively targets and inhibits PI3Kδ, leading to decreased cell proliferation and increased apoptosis.(伊替达利珠选择性靶向并抑制PI3Kδ,导致细胞增殖减少、凋亡增加。)
6. The combination of idelalisib and rituximab has been shown to improve outcomes in patients with relapsed chronic lymphocytic leukemia.(伊替达利珠和利妥昔单抗的联合疗法已被证明可以改善复发性慢性淋巴细胞白血病患者的预后。)
7. Idelalisib is indicated for the treatment of relapsed follicular lymphoma and relapsed small lymphocytic lymphoma.(伊替达利珠适用于复发性滤泡性淋巴瘤和复发性小淋巴细胞淋巴瘤的治疗。)
8. The most common adverse events associated with idelalisib include diarrhea, fever, and nausea.(与伊替达利珠相关的最常见不良反应包括腹泻、发热和恶心。)
9. Idelalisib has been shown to have a favorable safety profile in clinical studies.(临床研究表明,伊替达利珠具有良好的安全性。)
评论列表